Terje Bakken, Chairman (170866)
Terje is a partner in Reiten & Co and has been a part of the Reiten team since 1998. He has solid active investor experience through leading and implementing various strategic and operational value based processes, across different industries, combined with a significant financial transaction and finance experience. Mr Bakken holds a Master of Science in Financial Economics and Bachelor of Business and Administration degrees from the Norwegian School of Management. He has eight years of previous experience in management and consulting. Mr Bakken currently sits on the Board of Directors of Webstep ASA (Listed IT/IoT Consultancy company), QuestBack AS (Global SaaS company within the insight and feedback sector) and Grilstad AS. (A leading Brand within the Norwegian fast moving consumer goods industry)
Jostein Davidsen, Board member (070559)
Jostein Davidsen has been a board member in Navamedic since January 2017.Jostein brings more than 30 years of experience from the international pharmaceuticals industry, most recently serving as the Chief Executive Officer of the Acino Pharmaceuticals in Switzerland.
He previous founded NYCOMED Russia – CIS, that become one of the top leaders on the Russian - CIS pharmaceutical markets, which grew to over 1500 employees including local manufacturing in 2011 before Nycomed Pharma was acquired by Takeda Pharmaceuticals.
He served after the transaction as a Corporate Officer and the Head of the Emerging Markets at Takeda Pharmaceuticals International based in Zurich Switzerland. He was during this time named the world’s second most influential pharma-industry leader in Emerging Markets by Scrip (the pharmaceutical international news journal).
Davidsen studied Business and Administration at Handelsakademiet in Oslo and have completed several Executive Management Programs and Board learning program at IMD, Lausanne Switzerland.
Inger Johanne Solhaug, Board member (210869)
Inger Johanne has extensive experience from the fast moving consumer goods industry. She is currently Partner in XO Executive Advisors as an advisor within strategy, management, innovation and brand building. During 20 years in Orkla she held several
leading positions i.e. CEO in Nidar, Executive Vice President in Orkla ASA, Category Director in Orkla Foods and Assistant Category Director for Central Eastern Europe in Orkla Foods. Ms. Solhaug holds a Master of Business and Economics degree from the Norwegian School of Management. Ms. Solhaug owns 0 shares in Navamedic ASA.
Narve Reiten, Board member (011161)
Narve is the Founding Partner in Reiten & Co and established the firm in 1992. He has extensive investment and operational experience in the Nordic market. Mr Reiten holds a Master of Business and Economics degree from the Norwegian School of Management and is a Certified Financial Analyst (CFA) from the Norwegian School of Economics and Business Administration. Mr Reiten currently sits on the Board of Directors of Con-Form (Chairman) and Scanship Holding ASA (Chariman). Mr. Reiten will represent Ingerø Reiten Investment Company in the Board.
Cheng Lu, Board member
She is Director, Global Business Manager, in TopRidge Pharma and Global Business Manager in China Medical System Holdings Ltd and has experience as project leader from Xiang Ya Biomedicine Institute. She is Msc in Human Resource Management from King’s College in London and Bachelor of Business Administration from Wisconsin International University Ukraine. Ms. Lu will represent TopRidge Pharma in the Board, which holds 11,94 % of the shares in Navamedic ASA.